Clinical effect of different doses of Venlafaxine combined with Agomelatine in the treatment of refractory depression
JI Er-ni1 ZHU Lian2 CAI Lu-yao1
1.Department of Affective Disorders,Kangning Hospital of Shenzhen City,Guangdong Province,Shenzhen 518120,China; 2.Department of Medical Affairs,Kangning Hospital of Shenzhen City,Guangdong Province,Shenzhen 518120,China
Abstract:Objective To investigate the clinical effect of different doses of Venlafaxine and Agomelatine in the treatment of refractory depression.Methods A total of 82 patients with refractory depression who were admitted to the Department of Affective Disorders in Kangning Hospital of Shenzhen City from April 2016 to March 2018 were selected as study subjects.The patients were divided into observation group and control group,with 41 cases in each group.Patients in both groups were treated with Agomelatine Tablets after 1 week of drug washing.On this basis,patients in the control group were treated with Venlafaxine at 75-150 mg/d,while patients in the observation group were treated with Venlafaxine at 150-300 mg/d.After 7 weeks of treatment,the efficacy and incidence of adverse reactions such as headache,palpitations,dizziness,nausea,drowsiness and constipation were compared between the two groups.Results After treatment,the total effective rate of the observation group was 92.68%,which was higher than that of the control group (65.85%),the difference was statistically significant (P<0.05).The total incidence of adverse reactions such as headache,palpitations,dizziness,nausea,lethargy,and constipation in the observation group was 14.64%,compared with the control group (12.20%),the difference was not statistically significant (P>0.05).Conclusion According to the patients′ treatment,the dose of Venlafaxine is controlled in the range of 150-300 mg/d during the treatment,and the dose is increased as much as possible.In combination with Agomelatine in the treatment of refractory depression,the curative effect is remarkable,and the drug risk of adverse reactions is not increased,with high therapeutic safety,which is worthy of clinical application.
冀二妮; 朱 炼; 蔡璐遥. 不同剂量文拉法辛与阿戈美拉汀联合应用治疗难治性抑郁症的临床效果[J]. 中国当代医药, 2020, 27(1): 70-72.
JI Er-ni; ZHU Lian; CAI Lu-yao. Clinical effect of different doses of Venlafaxine combined with Agomelatine in the treatment of refractory depression. 中国当代医药, 2020, 27(1): 70-72.